The Global Pharma Regulatory Summit will bring together leading Regulatory experts and decision makers from across the pharma industry. Delegates will be attending this summit to learn about the latest updates on regulations, best practice and compliance advances in the sector and much more.
• Current amendments by USFDA, MHRA, ANVISA and Medicines for Europe
• Presentations by industry experts on Price Regulations, Clinical Trials, an overview of Nitrosamine Impurities and current regulations on Impurity Profiling
• In-depth panel discussions on global regulatory updates, Biopharma growth and regulatory perspectives in India
Our Director & CEO Mr. Sandeep Kulkarni was delivering an exclusive session on “Regulatory challenges in particle analysis process”.